Indicator 13: IPO and M&A
How Does Massachusetts Perform?
California and Massachusetts were the major generators of IPOs with each state's focus on advanced technology cluster development and large innovation economies. Massachusetts recorded more than a 50% increase in IPOs in 2018 (20) than in 2013 (13). Massachusetts IPOs were dominated by biotech and pharmaceutical companies in 2018 with 15 of the 20 IPOs. The average dollar amount raised in the IPO by these Massachusetts biotech companies was $145.2M.
Massachusetts had the same number of companies acquired in 2018 as in 2017 (168), while the number increased in 11 of the LTS. Every state save for New Jersey had an increase in the number of companies based there acquiring other firms.
Data Source for Indicator 13: Renaissance Capital, IPO Home, National Venture Capital Association (NVCA), Ipomonitor.com, Crunchbase.com